Metal labeled peptides for diagnostic imaging in cancer

Projektinformationen

ID Finanzhilfevereinbarung: QLK3-CT-2000-40562

Projekt abgeschlossen

Startdatum 15 Mai 2000

Enddatum 14 Mai 2001

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 30 000,00

EU-Beitrag € 22 500,00

Koordiniert durch

INBIOS
Italy

Ziel

The research project foresees the development of new molecular entities based onmetal-labeled peptides and peptidomimetics able to target with high affinity and selectivity receptor sites overexposed in human tumours. The receptors identified as the most attractive targets for the engineering of novel diagnostic tools are cholecystokinin and foliate. The new molecules will be used as diagnostic probes in nuclear medicine and magnetic resonance imaging depending upon the coordinated metal. The development of prototype contrast agents suitable for clinical diagnosis costumers in humans is the final goal.

Wissenschaftliches Gebiet

• natural sciences › biological sciences › biochemistry › biomolecules
• medical and health sciences › clinical medicine › radiology › nuclear medicine
• medical and health sciences › clinical medicine › oncology
• engineering and technology › medical engineering › diagnostic imaging › magnetic resonance imaging

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-3. - Key action The "Cell factory"

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

EAW - Exploratory awards

Koordinator

INBIOS

• EU-Beitrag: Keine Daten
• Adresse: Via A. Olivetti, 1 ; 80078 POZZUOLI ; Italien
• Gesamtkosten: Keine Daten

Beteiligte (1)

ISOGEN BIOSCIENCE BV

Niederlande

• EU-Beitrag: Keine Daten
• Adresse: Industrieweg 68 ; 3606 AS MAARSSEN
• Gesamtkosten: Keine Daten